347 related articles for article (PubMed ID: 35249546)
1. Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.
WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group
BMC Med; 2022 Mar; 20(1):85. PubMed ID: 35249546
[TBL] [Abstract][Full Text] [Related]
2. Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.
Zwang J; D'Alessandro U; Ndiaye JL; Djimdé AA; Dorsey G; Mårtensson AA; Karema C; Olliaro PL
BMC Infect Dis; 2017 Jun; 17(1):443. PubMed ID: 28645255
[TBL] [Abstract][Full Text] [Related]
3. Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.
Sagara I; Piarroux R; Djimde A; Giorgi R; Kayentao K; Doumbo OK; Gaudart J
Malar J; 2014 Sep; 13():358. PubMed ID: 25217396
[TBL] [Abstract][Full Text] [Related]
4. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.
; Dahal P; d'Alessandro U; Dorsey G; Guerin PJ; Nsanzabana C; Price RN; Sibley CH; Stepniewska K; Talisuna AO
BMC Med; 2015 Sep; 13():212. PubMed ID: 26343145
[TBL] [Abstract][Full Text] [Related]
5. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Chu CS; Douglas NM; Abreha T; Alemu SG; Añez A; Anstey NM; Aseffa A; Assefa A; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Grigg MJ; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Taylor WRJ; Thwaites G; Tran BQ; Hien TT; Vieira JLF; Wangchuk S; Watson J; William T; Woodrow CJ; Nosten F; Guerin PJ; White NJ; Price RN
BMC Med; 2019 Aug; 17(1):151. PubMed ID: 31366382
[TBL] [Abstract][Full Text] [Related]
6. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria.
Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE
Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260
[TBL] [Abstract][Full Text] [Related]
7. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
Hossain MS; Commons RJ; Douglas NM; Thriemer K; Alemayehu BH; Amaratunga C; Anvikar AR; Ashley EA; Asih PBS; Carrara VI; Lon C; D'Alessandro U; Davis TME; Dondorp AM; Edstein MD; Fairhurst RM; Ferreira MU; Hwang J; Janssens B; Karunajeewa H; Kiechel JR; Ladeia-Andrade S; Laman M; Mayxay M; McGready R; Moore BR; Mueller I; Newton PN; Thuy-Nhien NT; Noedl H; Nosten F; Phyo AP; Poespoprodjo JR; Saunders DL; Smithuis F; Spring MD; Stepniewska K; Suon S; Suputtamongkol Y; Syafruddin D; Tran HT; Valecha N; Van Herp M; Van Vugt M; White NJ; Guerin PJ; Simpson JA; Price RN
PLoS Med; 2020 Nov; 17(11):e1003393. PubMed ID: 33211712
[TBL] [Abstract][Full Text] [Related]
8. Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
Obonyo CO; Taylor W; Ekvall H; Kaneko A; Ter Kuile F; Olliaro P; Bjorkman A; Oloo AJ
Ann Trop Med Parasitol; 2007 Jun; 101(4):281-95. PubMed ID: 17524243
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
[TBL] [Abstract][Full Text] [Related]
10. Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.
Verhoeff FH; Brabin BJ; Masache P; Kachale B; Kazembe P; Van der Kaay HJ
Ann Trop Med Parasitol; 1997 Mar; 91(2):133-40. PubMed ID: 9307654
[TBL] [Abstract][Full Text] [Related]
11. Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
Sowunmi A; Akano K; Ayede AI; Ntadom G; Aderoyeje T; Adewoye EO; Fatunmbi B
BMC Infect Dis; 2016 Jun; 16():240. PubMed ID: 27246468
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
Sowunmi A; Fatunmbi B; Akano K; Wewe OA; Agomo C; Finomo F; Ebenebe J; Jiya N; Ambe J; Wammanda R; Ntadom G; Mokuolu O; Emechebe G; Ezeigwe N; Ayede AI; Adewoye EO; Gbotosho GO; Folarin OA; Happi CT; Oguche S; Oyibo WA; Useh F
BMC Infect Dis; 2017 Dec; 17(1):781. PubMed ID: 29258448
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Saito M; Mansoor R; Kennon K; Anvikar AR; Ashley EA; Chandramohan D; Cohee LM; D'Alessandro U; Genton B; Gilder ME; Juma E; Kalilani-Phiri L; Kuepfer I; Laufer MK; Lwin KM; Meshnick SR; Mosha D; Muehlenbachs A; Mwapasa V; Mwebaza N; Nambozi M; Ndiaye JA; Nosten F; Nyunt M; Ogutu B; Parikh S; Paw MK; Phyo AP; Pimanpanarak M; Piola P; Rijken MJ; Sriprawat K; Tagbor HK; Tarning J; Tinto H; Valéa I; Valecha N; White NJ; Wiladphaingern J; Stepniewska K; McGready R; Guérin PJ
BMC Med; 2020 Jun; 18(1):138. PubMed ID: 32482173
[TBL] [Abstract][Full Text] [Related]
14. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
[TBL] [Abstract][Full Text] [Related]
15. Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.
Stepniewska K; Allen EN; Humphreys GS; Poirot E; Craig E; Kennon K; Yilma D; Bousema T; Guerin PJ; White NJ; Price RN; Raman J; Martensson A; Mwaiswelo RO; Bancone G; Bastiaens GJH; Bjorkman A; Brown JM; D'Alessandro U; Dicko AA; El-Sayed B; Elzaki SE; Eziefula AC; Gonçalves BP; Hamid MMA; Kaneko A; Kariuki S; Khan W; Kwambai TK; Ley B; Ngasala BE; Nosten F; Okebe J; Samuels AM; Smit MR; Stone WJR; Sutanto I; Ter Kuile F; Tine RC; Tiono AB; Drakeley CJ; Gosling R; Stergachis A; Barnes KI; Chen I
BMC Med; 2022 Sep; 20(1):350. PubMed ID: 36109733
[TBL] [Abstract][Full Text] [Related]
16. Uncomplicated falciparum malaria among schoolchildren in Bajil district of Hodeidah governorate, west of Yemen: association with anaemia and underweight.
Alwajeeh TS; Abdul-Ghani R; Allam AF; Farag HF; Khalil SSM; Shehab AY; El-Sayad MH; Alharbi RA; Almalki SSR; Azazy AA
Malar J; 2020 Oct; 19(1):358. PubMed ID: 33028361
[TBL] [Abstract][Full Text] [Related]
17. Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA).
Thriemer K; Degaga TS; Christian M; Alam MS; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Karahalios A; Rajasekhar M; Simpson JA; Rumaseb A; Mnjala H; Lee G; Anose RT; Kidane FG; Woyessa A; Baird K; Sutanto I; Hailu A; Price RN
Trials; 2022 May; 23(1):416. PubMed ID: 35585641
[TBL] [Abstract][Full Text] [Related]
18. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group
Lancet Infect Dis; 2015 Jun; 15(6):692-702. PubMed ID: 25788162
[TBL] [Abstract][Full Text] [Related]
19. Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis.
WorldWide Antimalarial Resistance Network White Blood Cell Count in Malaria Study Group
Malar J; 2023 Jun; 22(1):174. PubMed ID: 37280686
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax infection: a major determinant of severe anaemia in infancy.
Kenangalem E; Karyana M; Burdarm L; Yeung S; Simpson JA; Tjitra E; Anstey NM; Poespoprodjo JR; Price RN; Douglas NM
Malar J; 2016 Jun; 15():321. PubMed ID: 27306221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
